Public Health Agency of Canada/Agence de santé publique du Canada
     
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
     
 

Notifiable Diseases On-Line

Haemophilus influenzae type b (Hib) is a bacterial infection that causes serious diseases in young children. The bacteria are spread by direct contact with or inhalation of the secretions from an infected person's nose or mouth. In the early 1990s, Hib was the most common cause of bacterial meningitis in Canada. Hib can be prevented by a vaccine. Since the introduction of a new vaccine, in 1992, the number of cases in Canada has decreased by more than 70%. The National Advisory Committee on Immunization (NACI) recommends that all children should be immunized against Hib at 2, 4 and 6 months with a fourth dose at 18 months (NACI-Recommended Childhood Vaccination Schedule, Canada).

HAEMOPHILUS INFLUENZAE TYPE B

AGENT OF DISEASE

Hib is caused by Haemophilus influenzae serotype b.

WORLDWIDE DISTRIBUTION

Occurrence is worldwide.

SYMPTOMS

Hib is most commonly associated with bacterial meningitis, but can also cause pneumonia and inflammation of the skin, joints, bone, throat and heart. Symptoms of meningitis develop 2 to 4 days after infection and include the sudden onset of fever, sore throat, severe headache, stiff neck and back, and sometimes breathing problems. In infants the soft part of the head (fontanelle) may bulge. Long-term effects include permanent hearing loss, paralysis, seizures and brain damage.

PERIOD OF COMMUNICABILITY

An infected person can transmit the infection as long as the bacteria are present in the body. With effective antibiotic treatment, a person becomes non-infectious within 24 to 48 hours.

HOW IT IS TRANSMITTED

The infection enters the body through the nose or mouth. The bacteria are spread by respiratory droplets and by direct contact with discharges from the nose and mouth of an infected person.

PREVENTION/CONTROL

Immunization of all children is recommended at 2, 4, and 6 months of age with a fourth dose at 18 months of age (NACI-Recommended Childhood Vaccination Schedule, Canada).

top

Last Updated: 2003-12-11